American Journal of Neuroradiology 25:1067-1076, June-July 2004
© 2004 American Society of Neuroradiology
INTERVENTIONAL
Intra-Arterial Nimodipine for the Treatment of Symptomatic Cerebral Vasospasm after Aneurysmal Subarachnoid Hemorrhage: Preliminary Results
a Department of Neuroradiology, Pitié-Salpêtrière Hospital–Paris VI University, Paris, France
b Department of Anesthesiology, Pitié-Salpêtrière Hospital–Paris VI University, Paris, France
c Department of Neurosurgery, Pitié-Salpêtrière Hospital–Paris VI University, Paris, France
d Department of Radiology, University of Messina, Italy
Address reprint requests to Alessandra Biondi, MD, Departement of Neuroradiology, Pitié-Salpêtrière Hospital, Paris VI University, 47/83 Boulevard de l’Hôpital, 75651 Paris, Cedex 13, France
BACKGROUND AND PURPOSE: Cerebral vasospasm remains a major problem in patients recovering from aneurysmal subarachnoid hemorrhage despite advances in medical, surgical, and endovascular care. Our purpose was to assess the efficacy of intra-arterial nimodipine, a calcium-channel blocker acting mainly on cerebral vessels, in preventing delayed neurologic deficits in patients with symptomatic vasospasm.
METHODS: Clinical charts of 25 consecutively treated patients were retrospectively reviewed. A multifactorial decision tree was used to determine the indication for angiography and subsequent endovascular treatment. Nimodipine was infused intra-arterially via a diagnostic catheter in the internal carotid artery or vertebral artery at a rate of 0.1 mg/min. Angiographic vasospasm before endovascular treatment, immediate vessel caliber modifications, and short- and long-term clinical efficacy of the procedure were assessed.
RESULTS: Thirty procedures were performed in 25 patients. Clinical improvement was observed in 19 (76%), 16 of whom improved after the first endovascular procedure, two after the second intra-arterial treatment, and one after the third. Of these 19 patients, only 12 (63%) had notable vascular dilatation at postprocedural angiography. Dilatation of infused vessels occurred in only 13 (43%) of 30 procedures. After follow-up of 3–6 months, 18 (72%) of 25 patients had a favorable outcome (Glasgow outcome scale score of 1–2 and modified Rankin scale score of 0–2). No complications were observed.
CONCLUSION: Intra-arterial nimodipine is effective and safe for the treatment of symptomatic vasospasm after subarachnoid hemorrhage. Further prospective randomized studies of cerebral blood flow are needed to confirm these results.
This article has been cited by other articles:
 |
|
 |
|
  J. B. Bederson, E. S. Connolly Jr, H. H. Batjer, R. G. Dacey, J. E. Dion, M. N. Diringer, J. E. Duldner Jr, R. E. Harbaugh, A. B. Patel, and R. H. Rosenwasser Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association Stroke, March 1, 2009; 40(3): 994 - 1025. [Full Text] [PDF]
|
|
|
|
 |
|
 R.G. Nogueira, M.H. Lev, L. Roccatagliata, J.A. Hirsch, R.G. Gonzalez, C.S. Ogilvy, E.F. Halpern, G.A. Rordorf, J.D. Rabinov, and J.C. Pryor Intra-Arterial Nicardipine Infusion Improves CT Perfusion-Measured Cerebral Blood Flow in Patients with Subarachnoid Hemorrhage-Induced Vasospasm AJNR Am. J. Neuroradiol., January 1, 2009; 30(1): 160 - 164. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Hanggi, B. Turowski, K. Beseoglu, M. Yong, and H.J. Steiger Intra-Arterial Nimodipine for Severe Cerebral Vasospasm after Aneurysmal Subarachnoid Hemorrhage: Influence on Clinical Course and Cerebral Perfusion AJNR Am. J. Neuroradiol., June 1, 2008; 29(6): 1053 - 1060. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. T. Fraticelli, B. P. Cholley, M.-R. Losser, J.-P. Saint Maurice, and D. Payen Milrinone for the Treatment of Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage Stroke, March 1, 2008; 39(3): 893 - 898. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Oran and C. Cinar Continuous Intra-Arterial Infusion of Nimodipine During Embolization of Cerebral Aneurysms Associated With Vasospasm AJNR Am. J. Neuroradiol., February 1, 2008; 29(2): 291 - 295. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.G. Tejada, R.A. Taylor, M.S. Ugurel, M. Hayakawa, S.K. Lee, and J.C. Chaloupka Safety and Feasibility of Intra-Arterial Nicardipine for the Treatment of Subarachnoid Hemorrhage-Associated Vasospasm: Initial Clinical Experience with High-Dose Infusions AJNR Am. J. Neuroradiol., May 1, 2007; 28(5): 844 - 848. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Biondi, L. Le Jean, L. Puybasset, H. S. Orer, M. M. Firat, and D. Belen Clinical Experience of Selective Intra-Arterial Nimodipine Treatment for Cerebral Vasospasm Following Subarachnoid Hemorrhage AJNR Am. J. Neuroradiol., March 1, 2006; 27(3): 474 - 474. [Full Text] [PDF]
|
|
|
|
|
|
D.Y. Yoon, C.S. Choi, K.H. Kim, and B.-M. Cho Multidetector-Row CT Angiography of Cerebral Vasospasm after Aneurysmal Subarachnoid Hemorrhage: Comparison of Volume-Rendered Images and Digital Subtraction Angiography. AJNR Am. J. Neuroradiol., February 1, 2006; 27(2): 370 - 377. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Arat and B. Cil Double-Balloon Remodeling of Wide-Necked Aneurysms Distal to the Circle of Willis AJNR Am. J. Neuroradiol., August 1, 2005; 26(7): 1768 - 1771. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Pelz, T. Andersson, P. Lylyk, M. Negoro, and M. Soderman Stroke Review: Advances in Interventional Neuroradiology 2004 Stroke, February 1, 2005; 36(2): 211 - 214. [Full Text] [PDF]
|
|